Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart Study
- PMID: 23544179
- PMCID: PMC3610922
- DOI: 10.1016/j.gheart.2012.12.008
Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart Study
Abstract
The role of diabetes in the pathogenesis of cardiovascular disease (CVD) was unclear until 1979 when Kannel et al used data from the Framingham Heart Study (FHS) to identify diabetes as a major cardiovascular risk factor. It was also one of the first studies to demonstrate the higher risk of CVD in women with diabetes compared to men with diabetes. Since then, multiple studies have been done to recognize and curtail cardiovascular risk factors such as smoking, obesity, hypertension, hyperlipidemia, and insulin resistance. This review will examine the contribution of the Kannel article and subsequent studies in defining the contribution of several risk factors on cardiovascular disease.
Conflict of interest statement
Conflict of Interest: None
Figures
References
-
- Friedberg CK. Diseases of the heart. WB Saunders Company; Philadelphia: 1949. p. 939.
-
- Kannel WB, McGee DL. Diabetes and Cardiovascular Disease. JAMA. 1979;241:2035–2038. - PubMed
-
- Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey. 2006. - PubMed
-
- Fox CS, Pencina MJ, Meigs JB, et al. Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study. Circulation. 2006;113:2914–2918. - PubMed
-
- Fox CS, Coady S, Sorlie PD, et al. Trends in cardiovascular complications of diabetes. JAMA. 2004;292:2495–2499. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
